세계의 수의용 백신 시장

Global Veterinary Vaccines Market to Reach US$14.6 Billion by 2030

The global market for Veterinary Vaccines estimated at US$10.5 Billion in the year 2024, is expected to reach US$14.6 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Poultry Vaccines segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 5.3% CAGR

The Veterinary Vaccines market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Veterinary Vaccines Market - Key Trends and Drivers Summarized

Why Are Veterinary Vaccines Crucial for Animal Health?

Veterinary vaccines are essential tools in safeguarding animal health, preventing the spread of infectious diseases, and promoting overall well-being in livestock, pets, and wildlife. These vaccines work by stimulating the animal's immune system to recognize and combat specific pathogens, reducing the incidence of diseases such as rabies, distemper, parvovirus, and avian influenza. For livestock, vaccinations are critical in ensuring the health of herds and flocks, thereby protecting food supply chains and minimizing economic losses for farmers. In companion animals, vaccines help maintain the health of pets, preventing potentially deadly diseases and reducing the risk of zoonotic infections that can be transmitted to humans. By controlling disease outbreaks, veterinary vaccines play a vital role in public health, food security, and the humane treatment of animals.

Not Just Animals, How Veterinary Vaccines Protect Us from Zoonotic Diseases?

Veterinary vaccines play a crucial role in reducing the risk of zoonotic diseases, which are infections transmitted from animals to humans. By immunizing animals, these vaccines prevent the initial establishment and subsequent spread of infectious agents among animal populations, thereby acting as a critical barrier against the transmission to humans. For instance, rabies vaccines administered to wildlife and domestic pets have significantly decreased the incidence of this fatal disease in humans. Similarly, vaccinating livestock against diseases like brucellosis and anthrax, which can be transmitted through direct contact or by consuming contaminated animal products, protects human health and enhances food safety. Furthermore, by controlling these diseases in animal populations, veterinary vaccines reduce the environmental load of pathogens, lowering the chance of human exposure and potential outbreaks. This proactive approach not only safeguards public health but also supports the welfare of domestic and wild animal populations, illustrating the intertwined health of humans and animals within shared ecosystems.

How Are Technological Advances Shaping Veterinary Vaccines?

Technological advancements are revolutionizing the field of veterinary vaccines, making them more effective, safer, and easier to administer. Innovations such as recombinant DNA technology and vector-based vaccines have enabled the development of vaccines that offer broader protection and longer-lasting immunity. For instance, subunit vaccines, which include only parts of the pathogen, reduce the risk of adverse reactions while still providing robust immunity. Additionally, advances in adjuvants-substances that enhance the immune response-are improving the efficacy of vaccines, especially in species that are difficult to immunize. Another significant development is the advent of oral and intranasal vaccines, which simplify administration, particularly in large-scale livestock operations. These innovations are not only enhancing the health and productivity of animals but also ensuring more sustainable and efficient agricultural practices.

What Challenges and Trends Are Impacting the Veterinary Vaccine Industry?

The veterinary vaccine industry faces several challenges, including the constant evolution of pathogens and the need for vaccines that can address multiple strains. The emergence of antibiotic-resistant bacteria underscores the importance of vaccines in reducing reliance on antibiotics, thereby mitigating the risk of resistance. Regulatory hurdles also pose significant challenges, as vaccines must undergo rigorous testing to ensure safety and efficacy, which can be time-consuming and costly. Despite these challenges, there are promising trends shaping the industry. There is a growing emphasis on developing vaccines for emerging diseases, supported by advances in genomics and bioinformatics that allow for rapid identification of pathogen targets. Additionally, the integration of big data and artificial intelligence is streamlining vaccine development processes and improving disease surveillance, enabling more proactive and targeted vaccination strategies.

What Drives the Growth in the Veterinary Vaccines Market?

The growth in the veterinary vaccines market is driven by several factors, including increasing pet ownership and the rising demand for animal-derived food products. As more people consider pets part of their family, there is a greater willingness to invest in preventive healthcare, including vaccinations. In the agricultural sector, the intensification of livestock farming and the need to ensure food safety and security drive the demand for effective vaccines to prevent disease outbreaks. Technological advancements that lead to the development of more effective and convenient vaccines also contribute to market expansion. Moreover, heightened awareness of zoonotic diseases and the role of veterinary vaccines in preventing these infections promote the adoption of vaccination programs. Regulatory support and initiatives to control and eradicate animal diseases further stimulate market growth, ensuring that veterinary vaccines remain a critical component of animal healthcare and public health initiatives.

SCOPE OF STUDY:

The report analyzes the Veterinary Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines, Other Types); Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Vaccines)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 22 Featured) -

• Bayer de Mexico SA de CV
• Biogenesis Bago SA
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Elanco Animal Health
• Heska Corporation
• Indian Immunologicals Ltd.
• Merck Animal Health
• Virbac SA
• Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Global Economic Update
  • Veterinary Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Zoonotic Diseases Drives Demand for Veterinary Vaccines
  • Innovations in Recombinant and DNA Vaccine Technologies Propel Market Growth
  • Increasing Awareness of Animal Health and Welfare Bolsters Vaccine Adoption
  • Global Expansion of Livestock Production and Companion Animal Ownership
  • Rise in Pet Ownership Bodes Well for Market Growth
  • Growth in Pet Insurance Market and Veterinary Care Spending
  • Consumer Trends Towards Organic and Antibiotic-Free Livestock Products
  • Development of Multivalent Vaccines to Address Multiple Pathogens
  • Environmental Concerns and the Use of Vaccines in Wildlife Conservation
  • Innovations in Aquaculture Vaccines Amidst Expanding Fish Farming Operations
  • Future Prospects in Veterinary Immunotherapy and Personalized Vaccines
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Veterinary Vaccines Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Live Attenuated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Recombinant Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Toxoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• JAPAN
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• CHINA
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• EUROPE
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• FRANCE
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: France 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• GERMANY
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 80: Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Germany Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Germany 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 86: Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Italy Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Italy 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Italy 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 92: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: UK Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: UK 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 95: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: UK Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: UK 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Rest of Europe 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Rest of Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Rest of Europe 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Asia-Pacific 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030
• REST OF WORLD
  • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Rest of World Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Rest of World 15-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2015, 2025 & 2030
  • TABLE 113: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of World Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of World 15-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2015, 2025 & 2030

IV. COMPETITION